Get the Stockscreener App
7.60
0.80%
0.06
After Hours:
3.43
-4.17
-54.87%
Mimedx Group Inc stock is traded at $7.60, with a volume of 526.78K.
It is up +0.80% in the last 24 hours and down -9.58% over the past month.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$7.54
Open:
$7.45
24h Volume:
526.78K
Relative Volume:
0.97
Market Cap:
$1.13B
Revenue:
$342.81M
Net Income/Loss:
$97.67M
P/E Ratio:
12.37
EPS:
0.6145
Net Cash Flow:
$50.46M
1W Performance:
-6.17%
1M Performance:
-9.58%
6M Performance:
+28.60%
1Y Performance:
-1.30%
1-Day Range:
$7.41
$7.65
1-Week Range:
$7.41
$8.08
52-Week Range:
$5.47
$10.14
Mimedx Group Inc Stock (MDXG) Company Profile
Name
Mimedx Group Inc
Sector
Industry
Phone
(770) 651-9100
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Compare MDXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
0.18 | 409.33M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.59 | 372.90M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.3243 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.96 | 139.95M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
8.97 | 115.09M | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-24 | Initiated | Lake Street | Buy |
| Oct-27-23 | Initiated | Craig Hallum | Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-26-21 | Initiated | Northland Capital | Outperform |
| Mar-19-21 | Initiated | H.C. Wainwright | Buy |
View All
Mimedx Group Inc Stock (MDXG) Latest News
Amniotic Membrane Market Focusing on Growth and Innovations - openPR.com
Avantax Advisory Services Inc. Reduces Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
MiMedx Group (NASDAQ:MDXG) Seems To Use Debt Rather Sparingly - Simply Wall St
Proficio Capital Partners LLC Purchases Shares of 46,089 MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
MiMedx Group, Inc.'s (NASDAQ:MDXG) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Charles Schwab Investment Management Inc. Decreases Stock Position in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
Top Executive Sells Shares in MiMedx Group! - TipRanks
MiMedx Challenges FDA Classification Of Wound Care Powder - Law360
Mimedx group chief commercial officer sells shares worth $14,142 By Investing.com - Investing.com Australia
Mimedx group chief commercial officer sells shares worth $14,142 - Investing.com India
MiMedx Group Executive Sells Shares to Cover Tax Liability - TradingView
Victory Capital Management Inc. Has $1.32 Million Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
Bank of New York Mellon Corp Has $4.85 Million Stock Position in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
Head-To-Head Analysis: MiMedx Group (NASDAQ:MDXG) and Stevanato Group (NYSE:STVN) - Defense World
Top Executives Unload Significant Shares of MiMedx Group - TipRanks
Mimedx group’s general counsel sells $430,762 in stock By Investing.com - Investing.com South Africa
Mimedx chief commercial officer sells shares for $32,396 By Investing.com - Investing.com Canada
Mimedx group’s general counsel sells $430,762 in stock - Investing.com
Mimedx chief commercial officer sells shares for $32,396 - Investing.com India
Mimedx group general counsel sells $635,278 in stock By Investing.com - Investing.com Australia
Mimedx group general counsel sells $635,278 in stock - Investing.com India
Where are the Opportunities in (MDXG) - Stock Traders Daily
Dermal Regeneration Template Market May Set a New Growth Story |Poietis , MiMedx Group - openPR
Proficio Capital Partners LLC Acquires Shares of 46,089 MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
Principal Financial Group Inc. Grows Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
Mimedx group chief commercial officer sells $17,742 in stock By Investing.com - Investing.com South Africa
Reviewing ICU Medical (NASDAQ:ICUI) and MiMedx Group (NASDAQ:MDXG) - Defense World
Mimedx group chief commercial officer sells $17,742 in stock - Investing.com India
Some May Be Optimistic About MiMedx Group's (NASDAQ:MDXG) Earnings - Simply Wall St
New York State Common Retirement Fund Buys 27,867 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
MiMedx Group, Inc. (NASDAQ:MDXG) Position Reduced by Rhumbline Advisers - Defense World
MiMedx Earnings Call: Growth Amidst Challenges - TipRanks
Cantor Fitzgerald Comments on MiMedx Group FY2025 Earnings - Defense World
Northland Capmk Forecasts Reduced Earnings for MiMedx Group - Defense World
Wolf Haldenstein: Mimedx Investor Reminder - ACCESS Newswire
Brokerages Set MiMedx Group, Inc. (NASDAQ:MDXG) Target Price at $12.00 - Defense World
Northland Capmk Forecasts Higher Earnings for MiMedx Group - Defense World
Beyond the Balance Sheet: What SWOT Reveals About MiMedx Group I - GuruFocus
MIMEDX to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewswire
MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2024 Earnings Call Transcript - Insider Monkey
When and Where to Catch MIMEDX's Latest Investor Presentation at the TD Cowen Conference - StockTitan
MiMedx Group Inc (MDXG) Q4 2024 Earnings: Revenue Surpasses Esti - GuruFocus.com
MiMedx: Q4 Earnings Snapshot - mySA
MiMedx Group Inc (MDXG) Q4 2024 Earnings Call Highlights: Strong - GuruFocus.com
MiMedx Group Inc (MDXG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
MiMedx Group, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Earnings call transcript: MiMedx beats Q4 2024 forecast, stock dips - Investing.com
Mimedx Group Inc Stock (MDXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
1.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):